Leading Focal Medical's research and technology development, my role blends R&D management with advancing drug delivery technologies to enhance patient outcomes in oncology and gene therapy. With a primary focus on a local pancreatic cancer drug delivery system slated for Phase 1b trials, my expertise in medical device development is pivotal in steering preclinical and research-stage projects towards clinical success.

As an advisor at Rilento Pharma, the technical development of novel oral surgery pain management technologies is under my guidance. In collaboration with the team, we've secured critical intellectual property and propelled the technology into preclinical testing, leveraging my extensive experience in product development and regulatory approval pathways for medical devices.

As a team leader and mentor for the NIH RADx and Blueprint MedTech programs, I’m helping to drive government funded medical technology moonshot programs that are accelerating innovations in COVID diagnostics and neuroscience.

Chief Technology Officer @ Focal Medical, Inc. | Medical Technology | Drug Delivery | Oncology | Gene Therapy | Analytical Chemistry | Polymer Physics | Biomaterials